Global Alzheimer - Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021

Report Description

FAQs

Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.

Global Alzheimer’s Disease Drugs Market and Pipeline Drugs Analysis

In 2016, the global market for Alzheimer’s disease drugs was dominated by Namenda, Memary, Aricept and Exelon. The combined market share of these four drugs was over 80% in the year 2016.
Ebixa, Razadyne/Reminyl, Rivastach and Nootropil are the other popular drugs in the Alzheimer’s disease market.
With the patent expiration of popular drugs the sales of the Alzheimer’s drugs have also declined. However, there are several pipeline drugs like Gantenerumab, Crenezumab and Aducanumab among others which are likely to hit the market during the period 2019 - 2020.

Global Alzheimer’s Disease Country Wise Analysis

In the Alzheimer’s disease drugs market, the United States is the largest market.
Japan is the second leading market for Alzheimer’s disease drugs market accounting for XXX% market share in 2016.
China stands at the third spot in the global Alzheimer’s disease drugs market being followed by India with XXX% share in the same year.
The EU5 countries together accounted for over 10% share of the global Alzheimer’s disease drugs market in 2016.

iGATE RESEARCH report titled “Global Alzheimer’s Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021” is a 189 Page report with 74 Figures and 14 Tables. This report provides a comprehensive assessment of the Alzheimer’s Disease Drugs Market, Alzheimer’s Disease Pipeline Drugs Market and Clinical Trials Analysis, Alzheimer’s Disease - Country Wise Drugs Market, Country Wise Alzheimer’s Disease Prevalence, Major Deals in Alzheimer’s Disease Drugs Market Landscape, Funding in Alzheimer’s Disease Drugs Research, Driving Factors and Challenges for Alzheimer’s Disease Drugs Market.

The Alzheimer’s Disease Drugs Market has been analyzed from 8 View Points:

Alzheimer’s Disease - Drugs Sales and Forecast
Alzheimer’s Disease - Pipeline Drugs Sales Forecast
Alzheimer’s Disease Drugs - Country Wise Market and Forecast
Alzheimer’s Disease - Country Wise Prevalence and Forecast
Alzheimer’s Disease – List of Pipeline Drugs in Various Phase of Development
Alzheimer’s Disease - Major Deals in Alzheimer’s Drugs Market
Alzheimer’s Disease - Funding in Alzheimer’s Disease Research
Alzheimer’s Disease Drugs Market – Driving Factors & Challenges

The Top 9 Alzheimer’s Disease Drugs covered in the report are as follows:

Exelon
Razadyne/Reminyl
Memary
Ebixa
Aricept
Rivastach
Namenda
Nootropil
Namzaric

The 3 Pipeline Alzheimer’s Disease Drugs covered in the report are as follows:

Gantenerumab
Crenezumab
Aducanumab

The 9 Countries Alzheimer’s Disease Drugs Market covered in the report are as follows:

United States
France
Germany
Italy
Spain
United Kingdom
Japan
China
India

List of Pipeline Alzheimer’s Disease Drugs in Various Phase of Development

Phase I
Phase II
Phase III

The Alzheimer’s Disease Drugs Major Deals covered in the report are as follows:

Strategic Alliance
Licensing Agreement
Collaboration Deals
Mergers and Acquisitions

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Single User License: This License type does not allow the report to be Printed.

Five User License: This License type does not allow the report to be Printed.

Enterprise License: This License type does not allow the report to be Printed.

Global License: This License type does not allow the report to be Printed.

Why http://www.marketreportsonline.com/

Global Alzheimer - Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021

Published By :iGate Research

How to Purchase

Purchase reports from our site in few easy clicks. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at our Payment Page on Paypal. You will see your Order Summary as well as an option to Choose a way to pay. Select a Payment option from Pay with a Paypal account OR Pay with a Debit or Credit Card. MarketReportOnline accepts Visa, MasterCard, American Express and Discover through Paypal. Fill up the required details in the option of your choice.

Step 4:

Once you follow the required process in Step 3 as mentioned above, you have successfully completed the purchase process.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. The report will then be emailed to you directly by the publisher, as per our agreement with the publisher. For Orders that are placed after working hours, the delivery of the reports will be made on the next business day. For orders that are placed during weekends, the delivery of the reports will be made on the next 'working' business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us.